We are live on ! Find out more
PXMD

PaxMedica, Inc. Common Stock

Delisted

PXMD was delisted on the 1st of May, 2024.

6 hedge funds and large institutions have $96.1K invested in PaxMedica, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
6
Holders Change
+6
Holders Change %
% of All Funds
0.1%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
Jane Street
1
Jane Street
New York
$43K +$59.8K +1,060 New
VF
2
Virtu Financial
New York
$34K +$46.9K +830 New
UBS Group
3
UBS Group
Switzerland
$15K +$20.6K +365 New
TRCT
4
Tower Research Capital (TRC)
New York
$4K +$6.21K +110 New
Bank of Montreal
5
Bank of Montreal
Ontario, Canada
$59 +$49.8K +882 New
Royal Bank of Canada
6
Royal Bank of Canada
Ontario, Canada
+$226 +4 New

PXMD Hedge Fund Activity: Q3 2022 in Review

6 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in PaxMedica, Inc. Common Stock (PXMD) for Q3 2022, worth a combined $96.1K.

Buyers outnumbered sellers: 6 funds opened new PXMD positions and 0 closed out — a net gain of 6 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Jane Street, opening a new position worth an estimated $59.8K.

  • 6 institutional investors held PaxMedica, Inc. Common Stock (PXMD) as of Q3 2022, up from 0 in Q2 2022.
  • Funds reported $96.1K of PaxMedica, Inc. Common Stock stock for Q3 2022.
  • 6 funds opened new PaxMedica, Inc. Common Stock positions in Q3 2022 and 0 closed out, a net change of +6 holders.
  • The largest PaxMedica, Inc. Common Stock buyer in Q3 2022 was Jane Street, an estimated $59.8K added.

Based on aggregated 13F filings for Q3 2022.